Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Clinical Psychopharmacology|November 16, 2007
Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind studyMichael Kluge, Andreas Schuld, Hubertus Himmerich, et al.
Pediatrics|February 5, 2008
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorderMark E Bangs, Philip Hazell, Marina Danckaerts, et al.
Psychoneuroendocrinology|October 7, 2008
Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced feverMichael Kluge, Andreas Schuld, Alexander Schacht, et al.
Schizophrenia Research|January 20, 2012
Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapineMichael Kluge, Hubertus Himmerich, Peter M Wehmeier, et al.
Psychiatric Genetics|November 30, 2005
Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairsFrank M Theisen, Stefan Gebhardt, Michael Haberhausen, et al.
Schizophrenia Research|October 10, 2008
Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 yearsMartin Lambert, Benno G Schimmelmann, Alexander Schacht, et al.
Schizophrenia Research|December 10, 2013
Olanzapine and clozapine differently affect sleep in patients with schizophrenia: results from a double-blind, polysomnographic study and review of the literatureMichael Kluge, Alexander Schacht, Hubertus Himmerich, et al.
Journal of Clinical Psychopharmacology|February 25, 2011
Differential 3-year effects of first- versus second-generation antipsychotics on subjective well-being in schizophrenia using marginal structural modelsMartin Lambert, Benno G Schimmelmann, Alexander Schacht, et al.
Journal of Child and Adolescent Psychopharmacology|February 26, 2008
Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label studyRalf W Dittmann, Eberhard Meyer, Franz Joseph Freisleder, et al.
Pageof 4